Skip to main content
. Author manuscript; available in PMC: 2023 Apr 25.
Published in final edited form as: Int J Pharm. 2022 Mar 8;618:121650. doi: 10.1016/j.ijpharm.2022.121650

Fig. 8.

Fig. 8.

Encapsulated CO prodrug formulation. a. BW-AC-306 packed in cellulose capsule (top), enteric gelatin capsule (middle), and kept in headspace vial for CO release study (bottom); CO release profile of BW-AC-306: b. packed in cellulose capsule and incubated in SGF; c. packed in enteric coated gelatin capsule and incubated in SGF for 1 h followed by changing the medium to SIF.